Home/Filings/4/0001808968-26-000003
4//SEC Filing

Klein Matthew B. 4

Accession 0001808968-26-000003

CIK 0001070081other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:20 PM ET

Size

7.6 KB

Accession

0001808968-26-000003

Insider Transaction Report

Form 4
Period: 2026-01-02
Klein Matthew B.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Common Stock

    2026-01-02+63,000405,132 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+157,500157,500 total
    Exercise: $76.74Exp: 2036-01-01Common Stock (157,500 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.
  • [F2]Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.
  • [F3]This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001808968

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:20 PM ET
Size
7.6 KB